It works by looking for a combination of "markers" in the blood which are different in healthy people and those with the disease. Delegates at the Alzheimer’s Research UK Conference heard that the University of Nottingham is now developing a quick and easy test to do in clinics. It could mean much earlier diagnosis and better treatments, they said.
The test uses some proteins that have been strongly linked with Alzheimer’s disease, such as amyloid and APOE. But through careful analysis of blood from people with the disease, as well as those with early-stage memory problems, the researchers detected some other markers that were suggestive of the disease.
Most notably, some proteins related to inflammation seem to have been added to increase the power of the test. Prof Kevin Morgan from the University of Nottingham said they still had to validate the test and it could be a decade before it was used in patients. But he added that the combination of markers they had found was looking very promising.
"Our findings are exciting because they show that it is technically possible to distinguish between healthy people and those with Alzheimer’s using a blood test.